Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Antoine MeyerMathurin FumeryLaurent Peyrin-BirouletJérôme FilippiRomain AltweggYoram BouhnikMelanie SerreroDavid LaharieXavier RoblinMaria NachuryVered AbitbolGuillaume CadiotStephane NanceyMatthieu AllezCyrielle GillettaLucine VuittonGuillaume SavoyeStephane NahonAnne BourrierAnthony BuissonGuillaume BouguenArnaud BourreilleStephanie ViennotFranck CarbonnelAurélien AmiotPublished in: Scandinavian journal of gastroenterology (2022)
In patients with UC for whom anti-TNF therapy failed, no difference was found between vedolizumab and ustekinumab after propensity scores weighted comparison. Further studies are required to determine predictive factors of the efficacy of both biological agents.